“…The following primary antibodies were used in this study. The monoclonal antibodies were as follows: 473HD (rat IgM) (Faissner et al, 1994), 487 (L5 epitope/LeX, rat IgM) (Streit et al, 1996), RC2 (mouse IgM; Developmental Studies Hybridoma Bank, University of Iowa, Iowa City, IA), O4 (mouse IgM) (Sommer and Schachner, 1981), polysialic-acid-containing neural cell adhesion molecule (PSA-NCAM) (Rougon et al, 1986), anti-nestin (mouse IgG; Chemicon, Temecula, CA), anti-III-tubulin (mouse IgG; Sigma, St. Louis, MO), and anti-5-bromo-2-deoxyuridine (BrdU) (mouse IgG; Roche Products, Welwyn Garden City, UK). The polyclonal antibodies (all rabbit) were against the following: DSD-1-PG/phosphacan [referred to as pk-anti-phosphacan, batch KAF 13(4)] (Faissner et al, 1994), GFAP (Dako, High Wycombe, UK), NG2 (Chemicon), brain lipid-binding protein (BLBP; gift from Dr. N. Heintz, Rockefeller University, New York, NY), and GLAST (gift from Dr. D. Pow, University of Queensland, Brisbane, Australia; or Chemicon).…”